Texas · Senate Bill 241 · 88th Legislature, Regular Session

Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.

  1. Introduced Nov 16, 2022
  2. In committee Feb 15, 2023
  3. Passed the Senate Mar 23, 2023
  4. Passed the House May 12, 2023
  5. To the governor May 16, 2023
  6. Became law May 27, 2023

Every action

52 steps, oldest first, as the legislature records them.

Show the 44 earlier steps
  1. SenateReceived by the Secretary of the Senate
  2. SenateFiled
  3. SenateRead first time
  4. SenateReferred to Health & Human Services
  5. CommitteeScheduled for public hearing on . . . · Senate Health & Human Services
  6. CommitteeNo action taken in committee · Senate Health & Human Services
  7. CommitteeScheduled for public hearing on . . . · Senate Health & Human Services
  8. CommitteeConsidered in public hearing · Senate Health & Human Services
  9. CommitteeTestimony taken in committee · Senate Health & Human Services
  10. CommitteeVote taken in committee · Senate Health & Human Services
  11. CommitteeReported favorably as substituted · Senate Health & Human Services
  12. SenateRecommended for local & uncontested calendar
  13. SenateCommittee report printed and distributed
  14. SenatePlaced on intent calendar
  15. SenateRules suspended-Regular order of business
  16. SenateRead 2nd time
  17. SenateAmendment(s) offered (FA1 Perry)
  18. SenateAmended
  19. SenateVote recorded in Journal
  20. SenatePassed to engrossment as amended
  21. SenateVote recorded in Journal
  22. SenateThree day rule suspended
  23. SenateRecord vote
  24. SenateRead 3rd time
  25. SenatePassed
  26. SenateRecord vote
  27. SenateReported engrossed
  28. HouseReceived from the Senate
  29. HouseRead first time
  30. CommitteeReferred to Public Health · House Public Health
  31. CommitteeConsidered in formal meeting · House Public Health
  32. CommitteeRecommended to be sent to Local & Consent · House Public Health
  33. CommitteeReported favorably w/o amendment(s) · House Public Health
  34. HouseComte report filed with Committee Coordinator
  35. HouseCommittee report distributed
  36. HouseComm. report sent to Local & Consent Calendar
  37. HouseConsidered in Local & Consent Calendars
  38. HousePlaced on Local, Consent, and Res. Calendar
  39. HouseRead 2nd time
  40. HousePassed to 3rd reading
  41. HouseNonrecord vote recorded in Journal
  42. HouseRead 3rd time
  43. HousePassed
  44. HouseRecord vote (RV#1580)
  1. HouseNonrecord vote recorded in Journal
  2. SenateHouse passage reported
  3. SenateReported enrolled
  4. SenateSigned in the Senate
  5. HouseSigned in the House
  6. GovernorSent to the Governor
  7. GovernorSigned by the Governor
  8. GovernorEffective on . . . . . . . . . . . . . . . (September 1, 2024)

Roll calls

4 recorded votes: 2 on the floor, 2 in committee. Each shows how every member voted.

Senator Perry moved that Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that CSSB 241 be placed on its third reading and final passage. — The motion prevailed · Full Senate

Passed 31–0
Mar 23, 2023 · journal entry
Yes 31 No 0
Democrats: 12 yes, 0 no Republicans: 19 yes, 0 no
How each member voted

Yes · 31

The bill was read third time and was passed · Full Senate

Passed 31–0
Mar 23, 2023 · journal entry
Yes 31 No 0
Democrats: 12 yes, 0 no Republicans: 19 yes, 0 no
How each member voted

Yes · 31

Committee and other votes

DateWhereQuestionResult
Mar 20, 2023 Senate Health & Human Services Health & Human Services: Reported favorably as substituted Passed 9–0
May 3, 2023 House Public Health Public Health: Reported favorably w/o amendment(s) Passed 9–0

Sponsors

The member who introduced it.

From Texas's official records (ftp.legis.state.tx.us), checked Nov 1, 2026. Text links go to the official versions; LegiList does not copy bill text.